For Research Use Only. Not for use in diagnostic procedures

Diagnosis of rare diseases presents many challenges for physicians and can lead patients on a long diagnostic odyssey.  DNA sequencing panels can provide physicians answers to these challenges and resolution for patients.  As a leader in rare disease diagnostics, CENTOGENE has partnered with Twist to design a series of target enrichment capture panels, providing comprehensive tools to aid in rare disease and hereditary oncology diagnosis.  

The Twist Alliance CNTG Exome - 41 MB provides highly uniform coverage of the entire exome as well as full coverage of the mitochondrial genome. Combining insights from CENTOGENE’s bio/databank with exceptional omics technology, the Twist Alliance CNTG Exome - 41 MB increases diagnostic yield compared to standard whole exome sequencing and covers a broad spectrum of disorders encompassing >7,000 rare diseases.  

Note: The Twist Alliance CNTG Exome - 41 MB  is not ISO-13485 certified.

Panel Information

• Total Probes 483K

• Twist Human Comprehensive Exome 396.1K

• Twist Mitochondrial Panel 139

• Twist Alliance Centogene Rare Disease Panel 78.8 K

• Centogene Spike-In 7.8 K